Kirn David — SEC Form 4 filings
SEC reporting owner CIK 1834021. 13 Form 4 filings on record with FilingPulse; latest filed 2026-09-16.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-01-25 to 2026-09-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 14 legs across 11 filings — 465,217 shares, $7,446,098 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 92,001 shares @ $27.13 ($2,495,822) in 4D Molecular Therapeutics, Inc., filed 2024-02-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| 4D Molecular Therapeutics, Inc. (FDMT) | See Remarks, Director | 13 | — | 14 legs · 465,217 sh · $7,446,098 | 10 |
Form 4 filings — Kirn David
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-16 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Sale (S): 58,333 @ $13.90 | EDGAR |
| 2026-08-21 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Option exercise (M): 50,000 @ $4.14 · Sale (S): 43,149 @ $15.36 · Sale (S): 25,927 @ $16.42 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2026-08-05 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Sale (S): 26,842 @ $10.23 | EDGAR |
| 2026-08-04 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Sale (S): 12,415 @ $10.05 | EDGAR |
| 2026-07-14 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Sale (S): 42,608 @ $12.87 · Sale (S): 15,283 @ $12.01 · Sale (S): 442 @ $12.84 | EDGAR |
| 2026-06-23 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Sale (S): 114,746 @ $10.47 | EDGAR |
| 2026-06-02 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Sale (S): 1,922 @ $10.02 | EDGAR |
| 2026-03-27 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/award (A): 750,000 (derivative) @ $0 | EDGAR |
| 2025-03-10 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/award (A): 267,500 (derivative) @ $0 | EDGAR |
| 2024-07-12 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Option exercise (M): 11,653 @ $14.42 · Option exercise (M): 1,270 @ $15.78 · Sale (S): 12,923 @ $22.49 · Option exercise (M): 11,653 (derivative) @ $0 · Option exercise (M): 1,270 (derivative) @ $0 | EDGAR |
| 2024-06-26 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Option exercise (M): 12,930 @ $14.42 · Sale (S): 12,930 @ $23.10 · Option exercise (M): 12,930 (derivative) @ $0 | EDGAR |
| 2024-02-12 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Sale (S): 92,001 @ $27.13 | EDGAR |
| 2024-01-25 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Sale (S): 5,696 @ $18.41 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1834021 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →